COMMUNIQUÉ DE PRESSE

par HBM Healthcare Investments AG (isin : CH0012627250)

Shareholders’ Meeting of HBM Healthcare Investments approved all proposals by the Board of Directors

HBM Healthcare Investments AG / Key word(s): AGMEGM
Shareholders’ Meeting of HBM Healthcare Investments approved all proposals by the Board of Directors

17.06.2024 / 17:53 CET/CEST


At today’s ordinary Shareholders’ Meeting of HBM Healthcare Investments Ltd the shareholders approved all proposals submitted by the Board of Directors.

The Chairman of the Board of Directors Hans Peter Hasler and the existing board members Dr Rudolf Lanz, Mario G. Giuliani,  Dr Stella X. Xu and Dr Elaine V. Jones were re-elected for a further one year term. The existing members of the Compensaiton Committee Mario G. Giuliani, Dr Stella X. Xu and Dr Elaine E. Jones were also re-elected for a further one year term.  Furthermore, the shareholders approved the proposed compensation to the Board of Directors and to the Management.

Further, the Shareholders’ Meeting approved a par value repayment of CHF 7.50 per share. The cash payment will be made on 9 August 2024. The registered shares with entitlement to the distribution will be traded for the last time on 6 August 2024 (from 7 August 2024 without, ex-date).

The presentation shown at the Shareholder’s Meeting 2024 can be accessed on the company's website at hbmhealthcare.com/en/investors/shareholders-meeting.

Contact
For further information, please contact Dr Andreas Wicki on +41 41 710 75 77, or at andreas.wicki@hbmhealthcare.com.



End of Media Release


Language:English
Company:HBM Healthcare Investments AG
Bundesplatz 1
6300 Zug
Switzerland
Phone:+41438887171
Fax:+41438887172
E-mail:info@hbmhealthcare.com
Internet:https://www.hbmhealthcare.com
ISIN:CH0012627250
Valor:1262725
Listed:SIX Swiss Exchange
EQS News ID:1926963

 
End of NewsEQS News Service

1926963  17.06.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1926963&application_name=news&site_id=symex~~~af100301-a623-4c64-8f3d-90fc88eca9e6
Voir toutes les actualités de HBM Healthcare Investments AG